These results suggest that although LPA2 enhances β-catenin phosphorylation in colon cancer cells that harbor a mutation in the Wnt/β-catenin pathway, LPA2 alone is not sufficient to modulate β-catenin in the absence of a predisposing mutation in Wnt pathway. The gene discussed is LPAR2; the disease is malignant colon neoplasm.